Physician profile
James Barlow
NPI 1982683405
$430.45
in general payments reported to CMS, 2019-2025
13 companies · $33.86 in 2025
The $33.86 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.64 · 2020: $16.78 · 2021: $98.90 · 2022: $62.03 · 2023: $37.51 · 2024: $136 · 2025: $33.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $89.84 | 2023-2025 | Libtayo, Dupixent |
| Sun Pharmaceutical Industries INC. | $57.32 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $47.94 | 2022 | |
| Galderma Laboratories, L.P. | $45.05 | 2019-2023 | |
| Genzyme Corporation | $29.98 | 2024 | |
| Boston Scientific Corporation | $26.79 | 2024 | Watchman Flx |
| Leo Pharma INC. | $24.57 | 2024 | Adbry |
| Janssen Biotech, INC. | $23.99 | 2021 | |
| Organogenesis INC. | $19.71 | 2019 | |
| Pfizer INC. | $17.59 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.78 | 2020 | |
| Amgen INC. | $16.75 | 2024 | Otezla |
| Osiris Therapeutics INC. | $14.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Barlow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.